{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:58:05Z","timestamp":1767664685853,"version":"3.44.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cpcardiol.2021.100912","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T23:29:31Z","timestamp":1622244571000},"page":"100912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thrombotic Events and Anticoagulants in Beta-thalassemia Patients with Focus on Anticoagulants for Atrial Fibrillation: A Brief Review"],"prefix":"10.1016","volume":"47","author":[{"given":"Saeide","family":"Bahrani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Teimouri-jervekani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2021.100912_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-5-11","article-title":"Beta-thalassemia","volume":"5","author":"Galanello","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0268-960X(87)90029-4","article-title":"Thalassaemia intermedia","volume":"1","author":"Wainscoat","year":"1987","journal-title":"Blood Rev"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0003","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.17554\/j.issn.2224-3992.2017.06.732","article-title":"Determination of genotype and viral load of HCV among Iranian thalassemic patients suffering from hepatitis","volume":"6","author":"Babaei","year":"2017","journal-title":"Journal of Gastroenterology and Hepatology Research"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0004","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.3109\/03630260903351619","article-title":"The hypercoagulable state in thalassemia intermedia","volume":"33","author":"Taher","year":"2009","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.V99.1.36","article-title":"The hypercoagulable state in thalassemia","volume":"99","author":"Eldor","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/793025","article-title":"Prevalence and risk factors for complications in patients with nontransfusion dependent alpha- and beta-thalassemia","volume":"2015","author":"Winichakoon","year":"2015","journal-title":"Anemia"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0007","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/jth.12698","article-title":"Thrombosis: a major contributor to the global disease burden","volume":"12","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0008","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1160\/TH06-05-0267","article-title":"Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran","volume":"96","author":"Taher","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0009","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.thromres.2013.09.029","article-title":"Thalassemia and the hypercoagulable state","volume":"132","author":"Sirachainan","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0010","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V77.8.1749.1749","article-title":"In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites","volume":"77","author":"Eldor","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.thromres.2018.10.016","article-title":"Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin","volume":"172","author":"Huang","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0012","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ajh.20945","article-title":"Hemostatic and thrombotic markers in patients with hemoglobin E\/beta-thalassemia disease","volume":"82","author":"Angchaisuksiri","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0013","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3324\/haematol.2009.010546","article-title":"Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma","volume":"94","author":"Tripodi","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0014","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2016.02.014","article-title":"Hypercoagulable state as demonstrated by thromboelastometry in hemoglobin E\/beta-thalassemia patients: Association with clinical severity and splenectomy status","volume":"140","author":"Natesirinilkul","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0015","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.22.3.294","article-title":"Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects","volume":"22","author":"Logothetis","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0016","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/0883073807300306","article-title":"Arterial Ischemic Stroke in a Child with \u03b2-Thalassemia Trait and Methylentetrahydrofolate Reductase Mutation","volume":"22","author":"Brankovic-Sreckovic","year":"2007","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/asheducation-2004.1.14","volume":"1","author":"Cohen","year":"2004","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0018","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.thromres.2011.07.046","article-title":"Normalized coagulation markers and anticoagulation proteins in children with severe \u03b2-thalassemia disease after stem cell transplantation","volume":"129","author":"Sirachainan","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0019","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00277-017-3070-2","article-title":"Normalized levels of red blood cells expressing phosphatidylserine, their microparticles, and activated platelets in young patients with \u03b2-thalassemia following bone marrow transplantation","volume":"96","author":"Klaihmon","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2141.1999.01758.x","article-title":"A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood","volume":"107","author":"Eldor","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0021","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2141.2000.02376.x","article-title":"Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia","volume":"111","author":"Cappellini","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0022","first-page":"449","article-title":"Significance of blood coagulation and platelet profiles in relation to pulmonary thrombosis in beta-thalassemia\/Hb E","volume":"25","author":"Visudhiphan","year":"1994","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0023","first-page":"65","article-title":"Protein C and protein S deficiency in thalassemic patients","volume":"23","author":"Shirahata","year":"1992","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0024","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000205945","article-title":"Protein C and Antithrombin III in Polytransfused Thalassemic Patients","volume":"77","author":"Musumeci","year":"1987","journal-title":"Acta Haematologica"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2141.1995.tb03381.x","article-title":"Low plasma heparin cofactor II levels in thalassaemia syndromes are corrected by chronic blood transfusion","volume":"90","author":"O'Driscoll","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0026","first-page":"516","article-title":"Pulmonary artery obstruction in thalassaemia","volume":"11","author":"Sonakul","year":"1980","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0027","first-page":"29","article-title":"Pulmonary microthromboemboli in thalassemic cases","volume":"23","author":"Sumiyoshi","year":"1992","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0028","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1378\/chest.98.5.1138","article-title":"Cardiopulmonary assessment in beta-thalassemia major","volume":"98","author":"Grisaru","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0029","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/08880019309016523","article-title":"Thalassemia: lung function with reference to iron studies and reactive oxidant status","volume":"10","author":"Luyt","year":"1993","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1203\/00006450-198601000-00005","article-title":"The effect of transfusion on lung capacity, diffusing capacity, and arterial oxygen saturation in patients with thalassemia major","volume":"20","author":"Grant","year":"1986","journal-title":"Pediatr Res"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0031","first-page":"93","article-title":"Right ventricular cardiac dysfunction in beta-thalassemia major","volume":"141","author":"Koren","year":"1987","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0032","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MPH.0000000000000670","article-title":"A Comparison of hemostatic changes in splenectomized and nonsplenectomized \u03b2-thalassemia intermedia patients","volume":"38","author":"Hashemieh","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0033","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00001721-200207000-00012","article-title":"Recurrent thromboembolism in a patient with beta-thalassemia major associated with double heterozygosity for factor V R506Q and prothrombin G20210A mutations","volume":"13","author":"Kahn","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0034","first-page":"41","article-title":"Oncologist","volume":"12","author":"Hashemieh","year":"2020","journal-title":"Thrombosis in thalassemia Thromboembolic Events in Severe Thalassemia Syndromes"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.hoc.2017.11.001","article-title":"Hypercoagulability and vascular disease","volume":"32","author":"Taher","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0036","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1468-1331.2011.03431.x","article-title":"Etiology and treatment of ischaemic stroke in patients with \u03b2-thalassemia major","volume":"18","author":"Vassilopoulou","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0037","doi-asserted-by":"crossref","first-page":"12249","DOI":"10.1002\/jcp.27968","article-title":"Atrial fibrillation in \u03b2-thalassemia patients with a focus on the role of iron-overload and oxidative stress: A review","volume":"234","author":"Nomani","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0038","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2012.037","article-title":"Exercise stress echocardiography with Tissue Doppler Imaging (TDI) detects early systolic dysfunction in beta-thalassemia major patients without cardiac iron overload","volume":"4","author":"Barbero","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0039","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/03630269.2018.1488724","article-title":"Atrial fibrillation in \u03b2-thalassemia major patients: diagnosis, management and therapeutic Options","volume":"42","author":"Barbero","year":"2018","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(71)90240-3","article-title":"Iron in the heart. Etiology and clinical significance","volume":"51","author":"Buja","year":"1971","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0041","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron overload cardiomyopathy in clinical practice","volume":"124","author":"Kremastinos","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0042","first-page":"281","article-title":"Cardiovascular function and treatment in \u03b2-thalassemia major: a consensus statement from the","volume":"128","author":"Pennell","year":"2013","journal-title":"American Heart Association. Circulation."},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0043","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ajh.21117","article-title":"Stroke in thalassemia: a dilemma","volume":"83","author":"Taher","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0044","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/03630269.2017.1374969","article-title":"Rivaroxaban Use in Patients with Hemoglobinopathies","volume":"41","author":"Apostolou","year":"2017","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0046","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.thromres.2015.03.003","article-title":"Aspirin resistance in children and young adults with splenectomized thalassemia diseases","volume":"135","author":"Sirachainan","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0047","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijcard.2016.10.045","article-title":"Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): analysis of 6-month outcomes","volume":"226","author":"Gaertner","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100912_bib0048","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2147\/TCRM.S84210","article-title":"New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events","volume":"11","author":"Mekaj","year":"2015","journal-title":"Ther Clin Risk Manag"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621001274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621001274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:00:13Z","timestamp":1758938413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280621001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0146280621001274"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100912","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic Events and Anticoagulants in Beta-thalassemia Patients with Focus on Anticoagulants for Atrial Fibrillation: A Brief Review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100912"}}